Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 1032-1036
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1032
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1032
Administration | Agents | Dosage (ng/kg) | Ulcer (mm2) | Inhibition ratio(%) |
im | Saline control | 131.2 ± 58.1 | ||
Excipient control | 130.2 ± 68.2 | |||
Famotidine | 40 000 | 55.7 ± 46.7 | 57.2b | |
BPC 157 | 200 | 80.9 ± 22.8 | 37.8b | |
BPC 157 | 400 | 47.6 ± 27.8 | 63.5b | |
BPC 157 | 800 | 44.8 ± 19.4 | 65.6b | |
ig | Saline control | 140.1 ± 78.1 | ||
Famotidine | 40 000 | 34.1 ± 33.1 | 75.7b | |
BPC 157 | 200 | 110.5 ± 41.5 | 21.1 | |
BPC 157 | 400 | 64.1 ± 35.4 | 54.2a | |
BPC 157 | 800 | 58.6 ± 37.6 | 58.2b |
- Citation: Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol 2004; 10(7): 1032-1036
- URL: https://www.wjgnet.com/1007-9327/full/v10/i7/1032.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i7.1032